Time to reconsider the role of ribavirin in Lassa fever.
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation o...
Saved in:
| Main Authors: | Alex Paddy Salam, Vincent Cheng, Tansy Edwards, Piero Olliaro, Jonathan Sterne, Peter Horby |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-07-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0009522 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics
by: Josephine Bourner, et al.
Published: (2025-02-01) -
The epidemiology of Lassa fever in Ghana: a study on the 2023 Lassa fever outbreak in Ghana
by: Kwasi Atweri Akowuah, et al.
Published: (2025-04-01) -
A Review of the Epidemiology of Lassa Fever in Nigeria
by: Danny Asogun, et al.
Published: (2025-06-01) -
Ribavirin Prophylaxis and Therapy of Experimental West Nile Fever
by: S. YA. Loginova, et al.
Published: (2020-05-01) -
Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
by: Anges Yadouleton, et al.
Published: (2020-01-01)